These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29200853)

  • 21. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
    Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
    J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
    [No Abstract]   [Full Text] [Related]  

  • 22. Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspective.
    Pan F; Peng S; Fleurence R; Linnehan JE; Knopf K; Kim E
    Clin Ther; 2010 Dec; 32(14):2444-56. PubMed ID: 21353113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging.
    Bastiat G; Pritz CO; Roider C; Fouchet F; Lignières E; Jesacher A; Glueckert R; Ritsch-Marte M; Schrott-Fischer A; Saulnier P; Benoit JP
    J Control Release; 2013 Sep; 170(3):334-42. PubMed ID: 23792117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.
    Eissa MM; El-Moslemany RM; Ramadan AA; Amer EI; El-Azzouni MZ; El-Khordagui LK
    PLoS One; 2015; 10(11):e0141788. PubMed ID: 26574746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine.
    Cashen AF; Devine H; DiPersio J
    Am J Hematol; 2006 Jul; 81(7):543-5. PubMed ID: 16755561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
    Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
    J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
    Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
    Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
    Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
    Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
    Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
    Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
    Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
    Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?
    Lowder JN; Taverna P; Issa JP
    Epigenomics; 2015 Oct; 7(7):1083-8. PubMed ID: 26541345
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
    Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers.
    Umerska A; Mouzouvi CR; Bigot A; Saulnier P
    Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133.
    Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E
    Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy.
    Wu W; Lin Y; Xiang L; Dong W; Hua X; Ling Y; Li H; Yan F; Xie X; Gu W
    Ann Hematol; 2016 Jun; 95(7):1051-7. PubMed ID: 27116384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells.
    Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z
    AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
    Nieto M; Demolis P; Béhanzin E; Moreau A; Hudson I; Flores B; Stemplewski H; Salmonson T; Gisselbrecht C; Bowen D; Pignatti F
    Oncologist; 2016 Jun; 21(6):692-700. PubMed ID: 27091416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes.
    Bohl SR; Dolnik A; Jensen T; Lang KM; Hackanson B; Gaidzik VI; Paschka P; Knudsen S; Döhner K; Döhner H; Claus R; Lübbert M; Bullinger L
    Leuk Lymphoma; 2017 Sep; 58(9):1-4. PubMed ID: 28278722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.